top of page
Loading...
Actuate Therapeutics, Inc. - Common stock (NQ:ACTU)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 2.380 |
| Bid (Size) | 1.650 (100) |
| Ask (Size) | 3.800 (200) |
| Prev. Close | 2.380 |
| Today's Range | 2.380 - 2.380 |
| 52wk Range | 1.580 - 11.99 |
| Shares Outstanding | 23,243,328 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
September 10, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 10, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 09, 2025
Pheton, Powell Max Make Public Debut ↗
September 08, 2024
Actuate Therapeutics Makes Public Debut ↗
August 18, 2024
Frequently Asked Questions
Is Actuate Therapeutics, Inc. - Common stock publicly traded?
Yes, Actuate Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Actuate Therapeutics, Inc. - Common stock trade on?
Actuate Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Actuate Therapeutics, Inc. - Common stock?
The ticker symbol for Actuate Therapeutics, Inc. - Common stock is ACTU on the Nasdaq Stock Market
What is the current price of Actuate Therapeutics, Inc. - Common stock?
The current price of Actuate Therapeutics, Inc. - Common stock is 2.380
When was Actuate Therapeutics, Inc. - Common stock last traded?
The last trade of Actuate Therapeutics, Inc. - Common stock was at 05/22/26 04:00 PM ET
What is the market capitalization of Actuate Therapeutics, Inc. - Common stock?
The market capitalization of Actuate Therapeutics, Inc. - Common stock is 55.32M
How many shares of Actuate Therapeutics, Inc. - Common stock are outstanding?
Actuate Therapeutics, Inc. - Common stock has 55M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page